Investing carries serious risks, including partial or total loss of capital. Please read the Key Investment Information Sheet and the Risk factors and login before investing.

Ugani Prosthetics 2A

Equity
State-of-the-art Prosthetics and Orthotics, at a fraction of the cost
Key Investment Information Sheet Terms & Conditions
€246,500
total amount raised in round
  • Backed by over 70 investors
  • Eligible for a tax reduction

The Market for Prosthetic & Orthotic Care: Expanding to Meet Global Demand 


Each year, over 1.5 million people lose limbs due to accidents, chronic illnesses, or war injuries. This staggering figure highlights the growing demand for accessible, high-quality prosthetic care. With the global prosthetics market valued at €1.4 billion in 2023 and projected to grow by 4-5% annually, the need for innovation in this space is more critical than ever ​​. Moreover, by 2050, the number of amputees worldwide is expected to double ​, amplifying the urgent call for scalable, cost-effective solutions that can meet the rising demand.

A kid in Kenya using prosthetic designed by Prothea Kenya with the Ugani worfklow

Addressing a Growing Global Need 


As the demand for prosthetic care rises, traditional solutions—often expensive and slow to produce—are becoming increasingly inadequate. High costs and lengthy production times make access to quality prosthetics a challenge, especially in regions where healthcare systems are seeking more sustainable, scalable options. 

Ugani’s 3D Pack offers a revolutionary alternative, streamlining the production process while significantly reducing costs, without compromising on quality. As awareness of the limitations of traditional methods grows, Ugani is uniquely positioned to capture a significant share of the market by providing clinics and healthcare providers with an accessible, cost-efficient solution that meets the needs of today’s patients. 

Expanding Capabilities Beyond Prosthetics 


Ugani’s innovative 3D technology goes beyond just prosthetics—it also facilitates the production of orthoses, expanding the range of mobility solutions available to clinics and healthcare providers. From prosthetic limbs to orthopedic devices, Ugani’s comprehensive technology allows workshops to manufacture a wide variety of assistive devices on-site. This versatility enables Ugani to reach a broader market, addressing the mobility needs of millions of patients, including those with conditions such as osteoarthritis and spinal injuries.

By offering solutions for both prosthetics and orthotics, Ugani’s Total Addressable Market (TAM) grows to an estimated €4.5 billion, presenting significant growth opportunities as the company continues to scale globally.

Targeting a Serviceable Market with Strategic Focus 


While the global P&O market holds vast potential, Ugani is honing in on a more focused Serviceable Addressable Market (SAM) of €500 million. This represents the revenue that could be captured by empowering all prosthetic workshops with Ugani’s innovative 3D printing technology. By decentralizing production and enabling local workshops to create affordable, high-quality P&O in-house, Ugani is addressing the key cost and logistical barriers that have long hindered the industry.

Ugani’s Serviceable Obtainable Market (SOM) is estimated at €50 million, reflecting the portion of the SAM that the company realistically expects to capture in the coming years based on its current strategy and resources. This estimate is primarily driven by sales in high- and middle-income regions such as Europe, the United States, and parts of Asia, where the demand for affordable, top-quality P&O is accelerating. In these markets, healthcare systems and private workshops are actively seeking cost-effective solutions without compromising on quality, positioning Ugani’s 3D Packs as an ideal choice for rapid scaling.

Global Trends Driving the Prosthetic Care Market 


Several key global trends are accelerating the demand for prosthetic care: 

  • Aging Population: By 2050, the global population aged 60 and older is expected to double, sharply increasing the need for mobility solutions, particularly in high-income countries .

  • Chronic Diseases: Conditions such as diabetes and cardiovascular disease are leading causes of amputations, especially in low- and middle-income regions where healthcare systems struggle to meet demand.

  • Technological Advancements: The rapid adoption of 3D printing, combined with breakthroughs in materials and design, is opening the door for scalable, cost-efficient solutions from companies like Ugani, offering a competitive edge in the evolving prosthetic care market. 

Market Segmentation: Tailored Solutions for Every Region 


Ugani’s strategy is designed to meet the diverse needs of regions with varying economic capacities. By leveraging its innovative 3D Packs, Ugani provides high-quality, cost-effective P&O in markets where demand is rising due to healthcare challenges and the increasing costs of traditional solutions. 
 
  • Middle-Income Countries (MIC)
    Regions such as Latin America, Southeast Asia, and parts of Eastern Europe present significant growth opportunities. These areas, with growing middle classes and more stable healthcare systems, are well-positioned to adopt Ugani’s 3D printing technology. Healthcare providers in these regions seek solutions that balance quality and affordability, and Ugani is well-placed to capture market share by offering a cost-effective alternative to traditional P&O.

  • High-Income Countries (HIC)
    In developed markets such as the USA, Canada, and Western Europe, demand for scalable, high-quality P&O continues to grow. The aging population, rise in chronic diseases, and high costs associated with traditional prosthetic methods are pushing healthcare providers and insurers to seek more efficient, value-based alternatives. Ugani’s 3D Pack delivers comparable or superior quality at a fraction of the cost, making it an attractive solution in these markets.

  • Low-Income Countries (LIC)
    Low-income regions remain a vital part of Ugani’s mission, and these areas will be served primarily through custom projects in collaboration with NGOs, international organizations, and governments, where needed with the support of the Ugani Foundation VZW. This dual approach allows Ugani to maintain its social mission while focusing commercial growth efforts on middle- and high-income countries. 

Scaling Globally 


Ugani has already embarked on its global expansion, targeting both undeserved and established markets. By the end of 2024, the company will have established partnerships across Europe, Asia, the Middle East and Africa, intending to expand into 50 countries over the next three years, leading to a global presence, also in the Americas and Oceania. The flexibility of Ugani's 3D Pack, combined with the DistributedFit Model, enables workshops to serve wide geographical regions at a fraction of the traditional cost. Each workshop equipped with a 3D Pack can cover an area as large as Western Europe, maximizing reach while minimizing operational costs.

A patient in Belgium using a prosthetic made by Ugani (@FrankToussaint)

Business Model: Empowering Local Prosthetists 


Ugani’s business model focuses on empowering local workshops rather than building a costly global infrastructure. By providing its technology to local partners, Ugani achieves broader market penetration while keeping overhead low. This approach strengthens the existing P&O ecosystem, enabling workshops to offer high-quality assistive devices at reduced costs and with greater efficiency.

Ugani partners become key brand ambassadors, playing an active role in expanding our network. By empowering them within a reseller model, Ugani extends its reach without requiring heavy investments in sales or business development. This collaborative approach ensures that everyone benefits from shared success and growth. 

Competition: Why Ugani Stands Out 


In a competitive global P&O market, Ugani stands out for several reasons: 
 
  1. Global Mindset
    While many competitors focus primarily on high-income markets, Ugani’s model is built to thrive in a variety of economic environments, ensuring scalability and long-term impact.

  2. Affordability
    Ugani's 3D Packs are 3-10 times more affordable than traditional methods or other 3D setups, making it accessible to workshops across low-, middle-, and high-income countries alike.

  3. Open-Source Flexibility
    Ugani's use of open-source technology allows prosthetists to adapt and innovate freely, customizing designs and devices without the burden of expensive licensing fees.

The global P&O market is growing rapidly, and Ugani is uniquely positioned to seize this opportunity. With its innovative 3D technology, scalable solutions, and growing demand in middle- and high-income regions, Ugani is set to disrupt the industry. For investors, this presents a rare opportunity to drive both financial returns and meaningful social change. The time to act is now.

TAX SHELTER 45%

Investments in this company benefit from a 45% personal income tax reduction. Read more…
A remaining amount of €62,746 is available for the Tax Shelter benefit.

Fact sheet

Advised by a professional start-up advisor
Valuation is set by the co-investor or incubator
Co-investor or incubator will be members or observers to the board
At the closing, an incubator, accelerator, or studio will have shares
At the closing, the entrepreneurs have contributed a minimum of €15,000 in cash in exchange for shares
Raised €10,000 during a private phase
At the closing, a professional co-investor will have invested at least €25,000
Prior fundraising in equity or convertible loan with 10 or more investors
Seasoned entrepreneurs
Minimum 2 active entrepreneurs
Valuation set by an organisation specialized in valuations of comparable size
Valuation is less than €1 million or 10x last year’s turnover

Raise summary

Crowd investments €246,500
Committed by others €0
Amount raised €246,500
Minimum round €25,000
Maximum round €400,500
Shares in the company (total round) 9.101%
Pre-money valuation €4,000,000
Post-money valuation min. €4,025,000
Post-money valuation max. €4,400,500